1989
DOI: 10.1073/pnas.86.12.4720
|View full text |Cite
|
Sign up to set email alerts
|

Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Abstract: Fatty acid compositions of plasma phospholipids, cholesteryl esters, triacylglycerols, and nonesterifiled fatty acids of 14 clinically proven and graded cases of multiple sclerosis were determined by capillary gas chromatography and compared with the values obtained for 100 normal, healthy subjects. In phospholipids, linoleic acid (18:2to6; 18 carbon atoms, 2 double bonds, 6 carbon atoms beyond last double bond) was normal and 18:3w6 was increased, but all subsequent w6 acids were subnormal (P < 0.001), indica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
57
0

Year Published

1991
1991
2013
2013

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(61 citation statements)
references
References 24 publications
1
57
0
Order By: Relevance
“…Nevertheless, there were deficiencies of essential PUFAs (ie PUFAs of the n-3 and n-6 series; Figure 1) in both plasma lipids and erythrocytes (Cherayil, 1984;Cunnane et al, 1989;Holman et al, 1989). Plasma linoleic acid (LA; 18:2n-6) was normal, and g-linolenic acid (GLA; 18:3n-6) increased in MS patients, but subsequent n-6 acids were subnormal, indicating impairment of chain elongation (Holman et al, 1989). In addition, the content of all n-3 fatty acids was subnormal and PUFA deficiency was compensated mass-wise by an increase in saturated fatty acids.…”
Section: Pufa Deficiencies In Msmentioning
confidence: 99%
“…Nevertheless, there were deficiencies of essential PUFAs (ie PUFAs of the n-3 and n-6 series; Figure 1) in both plasma lipids and erythrocytes (Cherayil, 1984;Cunnane et al, 1989;Holman et al, 1989). Plasma linoleic acid (LA; 18:2n-6) was normal, and g-linolenic acid (GLA; 18:3n-6) increased in MS patients, but subsequent n-6 acids were subnormal, indicating impairment of chain elongation (Holman et al, 1989). In addition, the content of all n-3 fatty acids was subnormal and PUFA deficiency was compensated mass-wise by an increase in saturated fatty acids.…”
Section: Pufa Deficiencies In Msmentioning
confidence: 99%
“…Results from the two groups of rats (control and iron overload) were compared using a two-sample independent t test with the Clinfo computer system. Fatty acid analyses were compared using normalcy ratios (19,20). P values of 0.05 or less were considered statistically significant.…”
Section: Introductionmentioning
confidence: 99%
“…Fatty acid methyl esters were extracted with petroleum ether and the percentage of individual fatty acids was determined with capillary gas chromatography using a bonded silica column (FFAP 2; Quadrex Corp., New Haven, CT). The double bond index was calculated by summing the products of mole fraction by number of double bonds per molecule for each fatty acid present in the sample (20).…”
Section: Introductionmentioning
confidence: 99%
“…The n-6 and n-3 polyunsaturated fatty acids, C18:2n-6, C20:4n-6 and C20:5n-3 have been reported to be decreased in plasma and blood cell membranes from these patients (Baker et al, 1964;Cherayil, 1984;Holman et al, 1989;Nightingale et al, 1990;Hon et al, 2009aHon et al, , 2009b, but other research groups have found no differences compared to control subjects (Cumings et al, 1965;Fisher et al, 1987;Evans & Dodd, 1989;Koch et al, 2006). Disturbed metabolic relationships between C18:2n-6 and C20:3n-6 (Harbige & Sharief, 2007), as well as between C20:3n-6 and C20:4n-6 (Harbige & Sharief, 2007;Hon et al, 2009b) in the peripheral blood mononuclear cell membranes from patients with multiple sclerosis have also been reported.…”
Section: Discussionmentioning
confidence: 93%